Benoit Guerette

Benoit Guerette serves as the Executive Director of Clinical Development in Inflammation and Rare Diseases at Amgen, where responsibilities include leading the US and Global Inflammation platform and overseeing Medical Affairs for Otezla®. Since joining Amgen in November 2019, Benoit has successfully integrated former Celgene Medical Affairs personnel and directed significant strategic planning for the product. Prior to Amgen, Benoit held various leadership roles at Celgene, including Vice President of US and Global Medical Affairs for Inflammation and Immunology, and played a pivotal role in the acquisition of Otezla®. Previous experience includes senior positions at AbbVie, Abbott Laboratories, and Bristol-Myers Squibb, focusing on market access and medical affairs in immunology. Benoit holds multiple advanced degrees and certifications from esteemed institutions, including Harvard Medical School and Université Laval.